What You Should Know About Breast Implants
If you’ve had reconstructive surgery or are thinking about it, take note.
Yesterday, the FDA announced a possible link between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma (ALCL). While ALCL is extremely rare, the FDA believes women with breast implants may have a very small but increased risk of developing this disease in the scar capsule adjacent to the implant.
The disease is diagnosed in only 3 of 100 million women in the United States without breast implants and the FDA is aware of about 60 cases of ALCL worldwide in women with breast implants, which is small compared to the estimated 5 to 10 million women who have implants worldwide. The FDA is asking health care providers to be vigilant in considering ALCL and reporting confirmed cases to the FDA for further study. Additionally, the FDA does not recommend that women without symptoms consider removal of their implants, nor do they suggest any change in routine medical care or follow-up.
We encourage you to know your body and what is normal for you. Report any changes to your breast to your oncologist or plastic surgeon and if you’re considering the procedure, talk to your surgeon about the risks and benefits.
About the author
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen and launched the global breast cancer movement. Today, Komen is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.